Skip to main content
Clinical and Experimental Gastroenterology logoLink to Clinical and Experimental Gastroenterology
. 2014 Oct 21;7:415–426. doi: 10.2147/CEG.S67776

Fungal infection of the colon

Surat Praneenararat 1,
PMCID: PMC4211850  PMID: 25364269

Abstract

Fungi are pathogens that commonly infect immunocompromised patients and can affect any organs of the body, including the colon. However, the literature provides limited details on colonic infections caused by fungi. This article is an intensive review of information available on the fungi that can cause colon infections. It uses a comparative style so that its conclusions may be accessible for clinical application.

Keywords: fungus, colitis, large bowel, large intestine

Introduction

Fungi are pathogens that commonly infect immunocompromised patients. At present, the incidence of these pathogens in disease causation is gradually increasing as a result of increased use of immunosuppressive drugs, chemotherapy, and transplantation as well as infections with the human immunodeficiency virus. Fungal infections can affect any organ, including the colon.13 Nevertheless, only limited details of colonic infection caused by fungi are available in the literature.4,5 This article aims to provide an intensive review of research on fungal infection of the colon in a concise, comparative style for easy clinical application.

Methods

The author initiated the review by researching fungi that can cause colonic infection on MEDLINE, in major textbooks, and existing research literature that review fungal infections of the colon.47 In MEDLINE, the author used keywords from two groups. The first group consisted of names of the fungi or infections related to the fungi, including “aspergillosis”, “Aspergillus”, “Blastomyces”, “blastomycosis”, “Candida”, “candidiasis”, “chromoblastomycosis”, “Cladophialophora”, “Coccidioides”, “ coccidioidomycosis”, “cryptococcosis”, “Cryptococcus”, “dermatophyte”, “dermatophytosis”, “Epidermophyton”, “eumycetoma”, “Fonsecaea”, “fusariosis”, “Fusarium”, “Histoplasma”, “histoplasmosis”, “Madurella”, “Microsporum”, “mucormycosis”, “Paracoccidioides”, “paracoccidioidomycosis”, “penicilliosis”, “Penicillium”, “phaeohyphomycosis”, “ Pneumocystis”, “pneumocystosis”, “scedosporiosis”, “Scedosporium”, “Sporothrix”, “sporotrichosis”, “Trichophyton”, “Trichosporon”, “trichosporonosis”, “Zygomycetes”, and “zygomycosis”. The second group of keywords consisted of words related to locations of the disease under our focus, including “colitis”, “colon”, “colonic”, “ enterocolitis”, “large bowel”, “large intestinal”, and “large intestine”. Finally, it was determined that infections of the colon that have been reported to be caused by fungi were aspergillosis, candidiasis, cryptococcosis, histoplasmosis, paracoccidioidomycosis, penicilliosis, pneumocystosis, scedosporiosis, and zygomycosis. Details of each fungus were further reviewed from articles retrieved on MEDLINE using the keywords as described above, citations to these articles, and references in major textbooks. In MEDLINE, all types of articles, including reviews, case series, case reports, editorials, and letters, up to June 30, 2014 were included. Initially, 124 articles were found. Only articles which were in English or had an English-language abstract with complete necessary detail that had a definite diagnosis of fungal infection of the colon, including direct visualization of typical fungus or positive fungal culture in colonic specimens, were selected. Cases of candidiasis, which is considered a normal commensal of the human gastrointestinal tract, also needed to have one of the following criteria as per the accepted case reports and revised European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria: deep tissue invasion in the colon, or positive Candida spp. in superficial mucosa with positive blood culture, or positive Candida spp. in superficial mucosa with evidence in response to treatment.814 Candida spp. in only superficial mucosa without positive blood culture or evidence in response to treatment were excluded. Dissemination was defined as involvement of two or more noncontiguous organs.1519

At present, histoplasmosis,20,21 candidiasis,13 and zygomycosis2225 have already been reviewed. In cases of other fungal infections, including cryptococcosis,2635 penicilliosis,3638 aspergillosis,9,3944 and paracoccidioidomycosis,4550 the author summarized case reports, as shown in Tables 14. Only one case report was published for each of pneumocystosis51 and scedosporiosis.52

Table 1.

Summary data of reported cases of colonic cryptococcosis

Source, year Age (years)/sex Origin of report Underlying disease/medication Clinical presentations Duration of onset Dissemination Colonic distribution Endoscopic finding Treatment and outcome
Zelman et al,26 1951 25/male USA CML, chemotherapy Not mentioned Not mentioned Yes Not mentioned Ulcer None → died
Unat et al,27 1960 16/male Turkey None Diarrhea, abdominal pain, LGIB 8 years No Descending colon Mass Surgery and amphotericin B → improved
Hutto et al,28 1988 29/female USA Job’s syndrome Rectal abscess 1 year No Perirectum, ascending colon Stricture at ascending colon and perirectal abscess Surgery and amphotericin B → improved
Van Calck et al,29 1988 47/male Belgium AIDS Hematochezia, fever Not mentioned Yes Perirectum Perirectal abscess Surgery, amphotericin B and flucytosine → improved
Daly et al,30 1990 63/male USA Cirrhosis, splenectomy, corticosteroids Fever, chills, malaise 7 days Yes Transverse colon Mass Amphotericin B and flucytosine → died
Bonacini et al,31 1990 31/male USA AIDS Hemiplegia, seizure Not mentioned Yes Not mentioned Not mentioned Amphotericin B and flucytosine → died
Washington et al,32 1991 38/male USA AIDS Epigastric pain, odynophagia 3 months Yes Cecum Not mentioned Antifungal therapy → died
Washington et al,32 1991 24/male USA Hodgkin’s disease Not mentioned Not mentioned Yes Not mentioned Not mentioned None → died
Washington et al,32 1991 31/female USA AIDS Not mentioned Not mentioned Yes Not mentioned Not mentioned None → died
Washington et al,32 1991 51/male USA Corticosteroids Not mentioned Not mentioned Yes Not mentioned Not mentioned None → died
Melato and Gorji,33 1998 84/female Italy None Rectal bleeding Acute No Sigmoid colon Polyp Polypectomy → improved
Law et al,34 2007 40/male Canada AIDS Abdominal pain, diarrhea, dysphagia, fever 6 weeks Yes Left colon Multiple erythematous, raised, patchy lesions Amphotericin B and flucytosine → improved
Song et al,35 2008 27/female Korea None Melena Not mentioned No Proximal ascending colon Mass Amphotericin B and fluconazole → improved

Abbreviations: AIDS, acquired immunodeficiency syndrome; CML, chronic myeloid leukemia; LGIB, lower gastrointestinal bleeding.

Table 4.

Summary data of reported cases of colonic paracoccidioidomycosis

Source, year Age(years)/sex Origin of report Underlying disease/medication Clinical presentations Duration of onset Dissemination Colonic distribution Endoscopic finding Treatment and outcome
Penna,45 1979 8/female Brazil None Diarrhea, abdominal pain, abdominal distension, fever, failure to thrive 4 years No Whole colon Stricture, ulcer Co-trimoxazole → improved
Chojniak et al,46 2000 57/not mentioned Brazil None Abdominal pain, diarrhea, weight loss 2 years No Cecum Mass Ketoconazole → not mentioned
Costa Vieira et al,47 2001 60/male Brazil None Fever, perianal nodule, dysphonia, cough, dyspnea weight loss 2 years Yes Transverse and Descending colons Ulcer Sulfadiazine → improved
Bravo et al,48 2010 39/female Peru None Diarrhea, abdominal pain, fever, weight loss 2 months Yes Whole colon Ulcer Amphotericin B → died
Leon et al,49 2010 34/male Peru None Diarrhea, oral ucers, odynophagia, weight loss, cough 18 months Yes Whole colon Ulcer Amphtotericin B and itraconazole → improved
Leon et al,49 2010 40/female Peru None Diarrhea, weight loss, hepatomegaly 1 year Yes Not mentioned Not mentioned Amphotericin B → died
Benard et al,50 2013 56/female Brazil None None (colonoscopy for check up) Unknown No Transverse colon Polyp Itraconazole → improved
Benard et al,50 2013 58/female Brazil None Diarrhea, weight loss, fever 6 months No Whole colon Ulcer Itraconazole → improved

Epidemiology

Candida spp. are normal commensals of the gastrointestinal tract,53,54 whereas Aspergillus spp. and Pneumocystis spp. are ubiquitous in nature5558 and are the cause of fungal infections worldwide. Cryptococcus spp. and Scedosporium spp. are endemic mycoses that also have worldwide distribution. Cryptococcus spp. have been isolated from pigeon droppings,59 while Scedosporium spp. have been found in tidal flats, swamps, ponds, manure, and soil.60,61 Aspergillus spp. and Cryptococcus spp. can also be found as a component of human colonic mycobiota.62

Zygomycetes can be divided into two orders, Mucorales and Entomophthorales. Mucorales are endemic fungi found worldwide in organic substrates, including bread, fruits, vegetable matter, soil, compost, and animal excreta.63 Histoplasma spp., Entomophthorales, Paracoccidioides spp., and Penicillium spp. are endemic mycoses that have been isolated from soil in a number of regions of the world.6371 Histoplasma spp. are found in soil enriched with bat, chicken, and blackbird droppings.64,65 Entomophthorales can be divided into Conidiobolus spp. and Basidiobolus spp. and are found in the soil of some tropical regions, especially Africa, South America, Central America, and Asia.63 Paracoccidioides spp. are limited to soil in Central and South American countries between 23° north (southern Mexico) and 34.5° north (Argentina and Uruguay). These areas have unique ecologic features, being tropical and subtropical forests with mild temperatures and high humidity.66,67 Penicillium spp. are also isolated from soil in specific areas including Southeast Asia, southern China (Guangxi), Hong Kong, and India.6871 The epidemiologic data is summarized in Table 5.

Table 5.

Epidemiology of fungi that can cause colonic infection

Fungi Epidemiology
Aspergillus spp.,55,56 Candida spp.,53,54 Cryptococcus spp.,59 Histoplasma spp.,64,65
Mucorales,63 Pneumocystis spp.,57,58 Scedosporium spp.60,61
Worldwide
Entomophthorales63 Tropical areas in Africa, South America, Central America, and Asia
Paracoccidioides spp.66,67 South and Central American countries, particularly in Brazil, Colombia, Venezuela, and Argentina
Penicillium spp.6871 Southeast Asia, southern China (Guangxi), Hong Kong, and India

Prevalence of colonic involvement

The degree of colonic involvement of fungal infections varies according to fungal type, as detailed in Table 6. Paracoccidioidomycosis and histoplasmosis are the most common colonic infections caused by fungi, with a prevalence of 29%72 and 28%,20 respectively. In contrast, penicilliosis, zygomycosis, pneumocystosis, and scedosporiosis rarely infiltrate the colon, with penicilliosis and zygomycosis occurring in 1.9%68 and 0.85% of colonic infections,25 respectively. Both pneumocystosis and scedosporiosis are known only from one case report.51,52 Excluding oropharyngeal candidiasis, the colon is the third most common gastrointestinal organ to be involved in candidiasis following the esophagus and stomach. The colon is involved in 20% of gastrointestinal candidiasis.73 Colonic cryptococcosis is the most common gastrointestinal manifestation of disseminated or pulmonary cryptococcosis, with a prevalence of about 17%.32

Table 6.

Prevalence of colonic involvement in each fungal infection

Fungal infections Prevalence of colonic involvement Comments
Paracoccidioidomycosis72 29% Prevalence ascertained by autopsy series
Histoplasmosis20 28%
Candidiasis73 20% of gastrointestinal candidiasis (excluding oropharyngeal candidiasis) Prevalence ascertained by autopsy series
Only seven symptomatic cases
Cryptococcosis32 17% of disseminated or pulmonary cryptococcosis
Aspergillosis74 9.2%
Penicilliosis68 1.9% Only four cases
Zygomycosis25 0.85%
Pneumocystosis51 No data Only one case
Scedosporiosis52 No data Only one case

Risk factors

Colonic cryptococcosis and zygomycosis often occur in immunocompromised hosts, occurring in 77%2635 and 67%22 of infections respectively, while colonic candidiasis,13 penicilliosis,3638 and aspergillosis9,3944 exclusively occur in immunocompromised hosts. Risk factors for these infections are malignancy, taking immunosuppressive agents, chemotherapy, neutropenia, AIDS, renal failure, splenectomy, Job’s syndrome, cirrhosis, malnutrition, and diabetes mellitus; however, most colonic penicilliosis patients usually have AIDS.37,38 There have also been case reports of colonic pneumocystosis and scedosporiosis in immunocompromised patients with AIDS and post-liver transplantation, respectively.51,52 In colonic paracoccidioidomycosis and histoplasmosis, there are no necessary risk factors present.20,21,4550 As shown in Table 7, males predominate in nearly all fungal infections, except for colonic candidiasis, aspergillosis, and paracoccidioidomycosis. The higher frequency of fungal infections in men may be attributed to their more intense exposure to the endemic fungi habitats through work.67 There is no sex preference in colonic candidiasis, since Candida spp. are normal commensals of the human gut.13,53,54 Aspergillus spp. are ubiquitous, thus sex is also not a risk factor for infection.9,3944,55,56 Although Paracoccidioidomycosis usually occur in men,67 females predominate are found in colonic paracoccidioidomycosis.4550 The author suggests that it may be caused by reporting bias.

Table 7.

Risk factors for fungal infections of the colon

Fungal infections Immunocompetent Immunocompromised Risk factors Male Comments
Paracoccidioidomycosis4550 100% 0% 29%
Histoplasmosis20,21 81% 19% Malignancy, immunosuppressive drugs, AIDS, Job’s syndrome, DM, splenectomy 76%–86.5%
Candidiasis13 0% 100% Malignancy, immunosuppressive agents, neutropenia, AIDS, ESRD 43%
Cryptococcosis2635 23% 77% AIDS, immunosuppressive agents, hematologic malignancy, splenectomy, Job’s syndrome, cirrhosis 64%
Aspergillosis9,3944 0% 100% Malignancy, chemotherapy, neutropenia, Immunosuppressive agents, DM, burn 33%
Penicilliosis3638 0% 100% AIDS (75%), immunosuppressive agents 100%
Zygomycosis22,24 33% 67% Immunosuppressive agents, malnutrition, renal failure, DM, hematologic malignancy 65%
Pneumocystosis51 0% 100% AIDS 100% Only one case
Scedosporiosis52 0% 100% Post-liver transplantation, immunosuppressive agents 100% Only one case

Abbreviations: AIDS, acquired immunodeficiency syndrome; DM, diabetes mellitus; ESRD, end-stage renal disease.

Immunity and colonic infection caused by fungi

Host immune response to fungi may play an important role in the pathogenesis of colonic infection caused by fungi, especially organisms that are part of the microbiota.75,76 Normally, innate immune cells have membrane-bound and soluble receptors to eliminate fungi. Membrane-bound receptors such as lectin, a toll-like scavenger, and complement receptors can detect fungi or fungal products and then activate phagocytosis and respiratory burst. Transcription factors which can induce proinflammatory cytokines and chemokines are also activated by membrane-bound receptors. Soluble receptors can further activate complements and opsonize fungi to complement receptors. Finally, T helper (Th) 1 and 17 are triggered and produce other cytokines including interleukin (IL)-17A, IL-17F, and IL-22 for adaptive immunity. Both innate and adaptive immune systems defend the host against fungi.76

There is some evidence that impaired immunity can increase colonic infection. IL-22, which is produced by innate cells and regulated by IL-23, has been demonstrated to activate inflammatory cells and thus control initial fungal growth.75 Defective IL-23 and IL-22 pathways increase the fungal burden in the gastrointestinal tract; nevertheless, Th1 cells prevent dissemination of fungi. Th17 cells play a major role in adaptive immune responses, though their impairment results in decreased resistance to late fungal infection. IL-17 receptor A deficiency reduces Th1 activation, thus decreasing fungal resistance.75 Therefore, immunosuppressive status is one of the major predisposing factors for colonic infection caused by fungi.

Clinical manifestations

Colonic infections caused by fungi have varied clinical manifestations, as detailed in Table 8. Excluding zygomycosis and aspergillosis, more than one-half of patients with colonic fungal infections have disseminated disease. Abdominal pain is the most common presentation in colonic zygomycosis and aspergillosis.9,22,24,3944 Deep tissue involvement and angioinvasion, which are common pathological findings in both aspergillosis and zygomycosis, may explain these manifestations.22,25,74 Diarrhea is a symptom that is often found in paracoccidioidomycosis and candidiasis.13,4550 Cases of colonic histoplasmosis and penicilliosis include diarrhea and abdominal pain as predominant symptoms.20,21,3638 Perirectal abscess is a specific feature that is only found in colonic cryptococcosis.28,29 Fever is a usual finding in fungal infection of the colon, especially in cases of colonic penicilliosis patients, all of whom experience fever.3638 For example, a case of colonic pneumocystosis presented with fever and diarrhea,51 while one with colonic scedosporiosis presented with diarrhea and abdominal pain.52

Table 8.

Clinical manifestations of colonic infections caused by fungi

Fungal infections Dissemination Diarrhea Abdominal pain LGIB Rectal abscess Fever Comments
Paracoccidioidomycosis4550 50% 75% 38% 50% Asymptomatic in 12.5%
Histoplasmosis20,21 83% 83% 67% 32% 77%
Candidiasis13 71% 57% 29% 29% 71%
Cryptococcosis2635 71% (all patients immunocompromised) 20% 30% 40% 20% 30% Asymptomatic in 20%
Aspergillosis9,3944 33% 22% 56% 33% 67%
Penicilliosis3638 50% 75% 75% 25% 100%
Zygomycosis22,24 38% 18% 64% 18% 55%
Pneumocystosis51 100% 100% 100% Only one case
Scedosporiosis52 100% 100% 100% Only one case

Note: Dissemination is defined as involvement of noncontiguous organs.1519

Abbreviation: LGIB, lower gastrointestinal bleeding.

Pathological findings and distribution

Colonic ulcer is the most common pathological finding in patients with fungal infection of the colon, as shown in Table 9. All cases of colonic aspergillosis, and penicilliosis have ulcers.3638,74 Ulcer is also usually found in colonic histoplasmosis, paracoccidioidomycosis, and candidiasis.21,4550,73 Colonic scedosporiosis, likewise, presents with ulcer.52 On the contrary, colonic cryptococcosis presents with a mass or polyp as the most common pathologic finding, while colonic cryptococcosis may also present with atypical pathologic findings, including rectal abscess or stricture.2635 Another colonic infection that can present with a mass or polyp is histoplasmosis.21 In one case of colonic pneumocystosis, the patient presented with bowel edema.51

Table 9.

Pathological findings of colonic infections caused by fungi

Fungal infections Ulcer Inflamed mucosa/erosion Pseudomembrane Mass/polyp Rectal abscess Stricture Comment
Paracoccidioidomycosis4550 63% 25% 13%
Histoplasmosis21 79% 14% 7%
Candidiasis73 64% 14% 23% From autopsy series
Cryptococcosis2635 11% 11% 44% 22% 11%
Aspergillosis74 100% (with necrosis 55.6%) From autopsy series
Penicilliosis3638 100%
Zygomycosis22,25 Ulcer, necrosis, mass occured, but numbers of patients not specified
Pneumocystosis51 100% Only one case
Scedosporiosis52 100% Only one case

Distributions of colonic infection caused by fungi differ according to fungus type, as shown in Table 10. Colonic histoplasmosis, zygomycosis, and penicilliosis tend to occur in the right side of the colon.20,23,3638 The rectal area tends to be involved in cases of histoplasmosis, candidiasis, and zygomycosis.13,20,23 Colonic cryptococcosis is the only fungus that involves the perirectal area.28,29 Diffuse involvement of the colon is commonly found in colonic paracoccidioidomycosis.4550 Cases of both colonic pneumocystosis and scedosporiosis also presented with diffuse lesions.51,52

Table 10.

Distributions of colonic infections caused by fungi

Fungal infections Cecum or ascending colon or appendix Transverse colon Descending or sigmoid colon Rectum Perirectum Whole colon Comments
Paracoccidioidomycosis4550 13% 25% 13% 50%
Histoplasmosis20 66% 8% 26%
Candidiasis13 20% 40% 20% 20%
Cryptococcosis2730,3235 30% 10% 40% 20%
Aspergillosis9,3944 33% 22% 22% 22%
Penicilliosis3638 50% 25% 25%
Zygomycosis23 50% 18% 7% 25%
Pneumocystosis51 100% Only one case
Scedosporiosis52 100% Only one case

Treatment response

Amphotericin B is the most commonly used drug to treat nearly all colonic fungal infections except candidiasis and pneumocystosis. Colonic candidiasis responds to fluconazole or caspofungin and has the best prognosis if antifungal therapy is initiated with 100% compliance.13 Good response was also achieved in colonic pneumocystosis and scedosporiosis.51,52 A case of colonic pneumocystosis was treated with intravenous pentamidine due to sulfamethoxazole–trimethoprim allergy.51 Combined antifungal therapy and surgery have been used to treat gastrointestinal zygomycosis and aspergillosis due to angioinvasion and infarction. Nevertheless, prognosis is still poor in these cases, with 50% mortality.25,39,41,43,44 The choices of antibiotic and treatment response of fungal infections are summarized in Table 11.

Table 11.

Treatment response of fungal infections in the colon

Fungal infections Treatment Treatment response Comments
Paracoccidioidomycosis45,4750 Co-trimoxazole, sulfadiazine, amphotericin B, or itraconazole 71%
Histoplasmosis21 Amphotericin B 77%
Candidiasis13 Fluconazole or caspofungin 100%
Cryptococcosis2735 Amphotericin B + flucytosine ± surgery 67% Response to treatment in immunocompetent patients was 100%
Aspergillosis39,41,43,44 Amphotericin B or caspofungin ± surgery 50%
Penicilliosis3638 Amphotericin B 75%
Zygomycosis25 Amphotericin B + surgery 50% Combined surgery improved treatment response
Pneumocystosis51 Pentamidine 100% Only one case
Scedosporiosis52 Amphotericin B 100% Only one case

Conclusion

This is the first study to intensively review the literature on fungal infections of the colon. The entire content is summarized in Table 12. It provides basic information on causes, manifestations, and management and can be easily applied in clinical practice. Physicians should be aware of this fungal entity when patients have colonic symptoms, especially in immunocompromised cases. Although many fungal infections have been reported to cause colonic disease, including aspergillosis, candidiasis, cryptococcosis, histoplasmosis, paracoccidioidomycosis, penicilliosis, pneumocystosis, scedosporiosis, and zygomycosis, knowing the differences in epidemiology, risk factors, clinical manifestations, and pathological findings will help physicians to better diagnosis and manage these infections. Appropriate treatment with antifungal therapy definitely improves outcomes; nevertheless, zygomycosis and aspergillosis cases still have high mortality rates.

Table 12.

Summary of colonic infection caused by fungi

Fungal infections Prevalence of colonic involvement Risk factors Clinical manifestations Dissemination Lesions Distribution Initial treatment Response
Paracoccidioidomycosis4550,72 29% • Endemic area (South America)
• Any host
Diarrhea, abdominal pain, fever 50% Ulcer, mass, polyp, stricture Whole colon Co-trimoxazole, sulfadiazine, amphotericin B, or itraconazole 71%
Histoplasmosis20,21 28% • Any host Diarrhea, abdominal pain, LGIB, fever, weight loss 83% Ulcer, edema mucosa mass Whole colon but predominantly right side of colon and rectum Amphotericin B 77%
Candidiasis13,73 20% of intestinal candidiasis in autopsy • Malignancy, immunosuppressive agents, neutropenia, AIDS, ESRD
• No immunocompetent patients
Diarrhea, abdominal pain, fever 71% Ulcer, plaque, erosion Whole colon Fluconazole or caspofungin 100%
Cryptococcosis2635 17% of disseminated or pulmonary cryptococcosis • AIDS, immunosuppressive agents, hematologic malignancy, splenectomy, Job’s syndrome, cirrhosis
• Immunocompetent patients (23%)
• Symptoms: LGIB, fever, abdominal pain, diarrhea, rectal abscess
• 20% asymptomatic
71% (all patients immunocompromised) Mass, perirectal abscess, colonic ulcer, patchy lesions, stricture, polyp Whole colon Amphotericin B + flucytosine ± surgery 60%
Aspergillosis9,3944,74 9.2% • Malignancy, chemotherapy, neutropenia, immunosuppressive agents, DM, burn
• No immunocompetent patients
Fever, abdominal pain, LGIB, diarrhea 86% Ulcer, necrosis Whole colon Amphotericin B or caspofungin ± surgery 50%
Penicilliosis3638,68 1.9% • Endemic area (Southeast Asia, southern China, Hong Kong, and India)
• Mostly AIDS (75%)
• No immunocompetent patients
Fever, diarrhea, abdominal pain, LGIB 50% Ulcer Predominantly in right side of colon and spare rectum Amphotericin B 75%
Zygomycosis2225 0.85% • Immunosuppressive agent, malnutrition, renal failure, DM, hematologic malignancy
• I mmunocompetent patients (33.3%)
Abdominal pain, abdominal distension, fever, LGIB, diarrhea 38% Ulcer, necrosis, mass Whole colon but predominantly in the right side of the colon Amphotericin B + surgery 50%
Pneumocystosis51 Only one case • AIDS Fever, diarrhea 100% Edema mucosa Whole colon Pentamidine 100%
Scedosporiosis52 Only one case • Post-liver transplantation, immunosuppressive agents Diarrhea, abdominal pain 100% Ulcer Whole colon Amphotericin B 100%

Abbreviations: AIDS, acquired immunodeficiency syndrome; DM, diabetes mellitus; ESRD, end-stage renal disease; LGIB, lower gastrointestinal bleeding.

Table 2.

Summary data of reported cases of colonic penicilliosis

Source, year Age (years)/sex Origin of report Underlying disease/medication Clinical presentations Duration of onset Dissemination Colonic distribution Endoscopic finding Treatment and outcome
Tsang et al,36 1988 58/male Hong Kong Corticosteroids Fever, anemia, hepatosplenomegaly Acute Yes Descending colon Ulcer Amphotericin B → died
Leung et al,37 1996 32/male Hong Kong AIDS Fever, diarrhea, night sweats, dry cough Acute No Cecum, transverse and descending colons Ulcer Amphotericin B and itraconazole → improved
Ko et al,38 1999 52/male Taiwan AIDS Fever, diarrhea, anemia, abdominal pain 3 weeks Yes Cecum Ulcer Amphotericin B and itraconazole → improved
Ko et al,38 1999 30/male Taiwan AIDS Dyspepsia, diarrhea, fever, abdominal pain, LGIB, weight loss 2 months No Cecum, ascending and transverse colons Ulcer Amphotericin B and itraconazole → improved

Abbreviations: AIDS, acquired immunodeficiency syndrome; LGIB, lower gastrointestinal bleeding.

Table 3.

Summary data of reported cases of colonic aspergillosis

Source, year Age (years)/sex Origin of report Underlying disease/medication Clinical presentations Duration of onset Dissemination Colonic distribution Endoscopic finding Treatment and outcome Diagnosed from
Kinder and Jourdan,39 1985 37/female UK Post-renal transplant, immunosuppressive agents LGIB Acute Yes Cecum and sigmoid colon Ulcer Amphotericin B and surgery → died Deep tissue involvement in surgical specimen
Prescott et al,9 1992 62/female UK AML, chemotherapy, neutropenia Fever, abdominal pain, diarrhea, and vomiting Acute No Not mentioned Ulcer Not mentioned → died Deep tissue involvement in autopsy
Prescott et al,9 1992 43/male UK CML, chemotherapy, neutropenia Fever Acute Yes Transverse colon Pseudomembrane Not mentioned → died No deep tissue involvement in colon but definite other organ involvement
Prescott et al,9 1992 66/female UK CA stomach, chemotherapy, neutropenia Fever Acute Yes Transverse colon Necrosis Not mentioned → died Deep tissue involvement in autopsy
Sousa et al,40 2002 21/female Portugal Aplastic anemia Fever, abdominal pain Subacute No Cecum Mass Surgery → died Deep tissue involvement in surgical specimen
Finn et al,41 2006 75/female Ireland Aplastic anemia, immunosuppressive agents Fever, abdominal pain Acute No Cecum Ulcer with necrosis Amphotericin B and surgery → died Deep tissue involvement in surgical specimen
Andres et al,42 2007 42/female USA Burn Abdominal pain, distension, LGIB Acute No Whole colon Necrosis None Deep tissue involvement in surgical specimen
Mohite et al,43 2007 42/male UK AML, chemotherapy, neutropenia Fever, diarrhea, abdominal pain, Abdominal distension Acute No Whole colon Ulcer with necrosis Caspofungin and surgery → improved Deep tissue involvement in surgical Specimen and responded to treatment
Choi et al,44 2010 72/male Korea DM, steroid, CA colon LGIB Acute No Sigmoid colon and descending colon Ulcer Amphotericin B → improved Responded to treatment

Abbreviations: AML, acute myeloid leukemia; CA, cancer; CML, chronic myeloid leukemia; DM, diabetes mellitus; LGIB, lower gastrointestinal bleeding.

Footnotes

Disclosure

The author reports no conflicts of interest in this work.

References

  • 1.Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical Mycology. New York, NY: Churchill Livingstone; 2003. [Google Scholar]
  • 2.Dismukes WE, Pappas PG, Sobel JD, editors. Clinical Mycology. New York, NY: Oxford University Press; 2003. [Google Scholar]
  • 3.Hospenthal DR, Rinaldi MG, editors. Diagnosis and Treatment of Human Mycoses. Totowa, NJ: Humana Press; 2008. [Google Scholar]
  • 4.Smith JM. Mycoses of the alimentary tract. Gut. 1969;10:1035–1040. [PMC free article] [PubMed] [Google Scholar]
  • 5.Schmitt SL, Wexner SD. Bacterial, fungal, parasitic, and viral colitis. Surg Clin North Am. 1993;73(5):1055–1062. doi: 10.1016/s0039-6109(16)46140-2. [DOI] [PubMed] [Google Scholar]
  • 6.Lima AAM, Guerrant RL. Inflammatory enteritides. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2009. pp. 1389–1398. [Google Scholar]
  • 7.Wilcox CM. Gastrointestinal consequences of infection with human immunodeficiency virus. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 9th ed. Philadelphia, PA: Saunders Elsevier; 2010. pp. 523–535. [Google Scholar]
  • 8.Stylianos S, Forde KA, Benvenisty Al, Hardy MA. Lower gastrointestinal hemorrhage in renal transplant recipients. Arch Surg. 1988;123:739–744. doi: 10.1001/archsurg.1988.01400300085015. [DOI] [PubMed] [Google Scholar]
  • 9.Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol. 1992;45:806–811. doi: 10.1136/jcp.45.9.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jayagopal S, Cervia JS. Colitis due to Candida albicans in a patient with AIDS. Clin Infect Dis. 1992;15:555. doi: 10.1093/clind/15.3.555. [DOI] [PubMed] [Google Scholar]
  • 11.Kouklakis G, Dokas S, Molyvas E, Vakianis P, Efthymiou A. Candida colitis in a middle-aged male receiving permanent haemodialysis. Eur J Gastroenterol Hepatol. 2001;13:735–736. doi: 10.1097/00042737-200106000-00021. [DOI] [PubMed] [Google Scholar]
  • 12.Kitagawa KH, Kalb RE. Efalizumab treatment associated with Candida colitis. J Am Acad Dermatol. 2008;59(suppl 5):S120–S121. doi: 10.1016/j.jaad.2008.06.035. [DOI] [PubMed] [Google Scholar]
  • 13.Praneenararat S. The first reported case of colonic infection caused by Candida tropicalis and a review of the literature. Case Rep Gastroenterol. 2014;8:199–205. doi: 10.1159/000363566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–1821. doi: 10.1086/588660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ascioglu S, Rex JH, de Pauw B, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer. Mycoses Study Group of the National Institute of Allergy and Infectious Diseases Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14. doi: 10.1086/323335. [DOI] [PubMed] [Google Scholar]
  • 16.Safdar A, Singhal S, Mehta J. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993–2001) Cancer. 2004;100:2456–2461. doi: 10.1002/cncr.20262. [DOI] [PubMed] [Google Scholar]
  • 17.Kontoyiannis DP, Bodey GP, Hanna H, et al. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma. 2004;45:139–141. doi: 10.1080/1042819031000149386. [DOI] [PubMed] [Google Scholar]
  • 18.Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect. 2004;10:922–925. doi: 10.1111/j.1469-0691.2004.00933.x. [DOI] [PubMed] [Google Scholar]
  • 19.Safdar A, Rodriguez G, Rolston KV, et al. High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39(3):157–164. doi: 10.1038/sj.bmt.1705559. [DOI] [PubMed] [Google Scholar]
  • 20.Cappell MS, Mandell W, Grimes MM, Neu HC. Gastrointestinal histoplasmosis. Dig Dis Sci. 1988;33:353–360. doi: 10.1007/BF01535762. [DOI] [PubMed] [Google Scholar]
  • 21.Assi M, McKinsey DS, Driks MR, et al. Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review. Diagn Microbiol Infect Dis. 2006;55:195–201. doi: 10.1016/j.diagmicrobio.2006.01.015. [DOI] [PubMed] [Google Scholar]
  • 22.Lyon DT, Schubert TT, Mantia AG, Kaplan MH. Phycomycosis of the gastrointestinal tract. Am J Gastroenterol. 1979;72(4):379–394. [PubMed] [Google Scholar]
  • 23.Agha FP, Lee HH, Boland CR, Bradley SF. Mucormycoma of the colon: early diagnosis and successful management. AJR Am J Roentgenol. 1985;145:739–741. doi: 10.2214/ajr.145.4.739. [DOI] [PubMed] [Google Scholar]
  • 24.Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–653. doi: 10.1086/432579. [DOI] [PubMed] [Google Scholar]
  • 25.Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6:2365–2374. doi: 10.1111/j.1600-6143.2006.01496.x. [DOI] [PubMed] [Google Scholar]
  • 26.Zelman S, O’Neil RH, Plaut A. Disseminated visceral torulosis without nervous system involvement with clinical appearance of granulocytic leukemia. Am J Med. 1951;11:658–664. doi: 10.1016/0002-9343(51)90098-8. [DOI] [PubMed] [Google Scholar]
  • 27.Unat EK, Pars B, Kosyak JP. A case of cryptococcosis of the colon. Br Med J. 1960;2:1501–1502. doi: 10.1136/bmj.2.5211.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI. Cryptococcosis of the colon resembling Crohn’s disease in a patient with the hyperimmunoglobulinemia E recurrent infection (Job’s) syndrome. Gastroenterology. 1988;94:808–812. doi: 10.1016/0016-5085(88)90257-0. [DOI] [PubMed] [Google Scholar]
  • 29.Van Calck M, Motte S, Rickaert F, Serruys E, Adler M, Wybran J. Cryptococcal anal ulceration in a patient with AIDS. Am J Gastroenterol. 1988;83:1306–1308. [PubMed] [Google Scholar]
  • 30.Daly JS, Porter KA, Chong FK, Robillard RJ. Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient. Am J Gastroenterol. 1990;85:1421–1424. [PubMed] [Google Scholar]
  • 31.Bonacini M, Nussbaum J, Ahluwalia C. Gastrointestinal, hepatic, and pancreatic involvement with Cryptococcus neoformans in AIDS. J Clin Gastroenterol. 1990;12:295–297. doi: 10.1097/00004836-199006000-00012. [DOI] [PubMed] [Google Scholar]
  • 32.Washington K, Gottfried MR, Wilson ML. Gastrointestinal cryptococcosis. Mod Pathol. 1991;4:707–711. [PubMed] [Google Scholar]
  • 33.Melato M, Gorji N. Primary intestinal cryptococcosis mimicking adenomatous polyp in an HIV-negative patient. Am J Gastroenterol. 1998;93:1592–1593. doi: 10.1111/j.1572-0241.1998.00492.x. [DOI] [PubMed] [Google Scholar]
  • 34.Law JK, Amar JN, Kirby SD, Zetler PJ, Enns RA. Colonic cryptococcus infection. Gastrointest Endosc. 2007;65:525–526. doi: 10.1016/j.gie.2006.08.043. [DOI] [PubMed] [Google Scholar]
  • 35.Song JC, Kim SK, Kim ES, et al. A case of colonic cryptococcosis. Korean J Gastroenterol. 2008;52:255–260. Korean. [PubMed] [Google Scholar]
  • 36.Tsang DN, Chan JK, Lau YT, Lim W, Tse CH, Chan NK. Penicillium marneffei infection: an underdiagnosed disease? Histopathology. 1988;13:311–318. doi: 10.1111/j.1365-2559.1988.tb02041.x. [DOI] [PubMed] [Google Scholar]
  • 37.Leung R, Sung JY, Chow J, Lai CK. Unusual cause of fever and diarrhea in a patient with AIDS. Penicillium marneffei infection. Dig Dis Sci. 1996;41:1212–1215. doi: 10.1007/BF02088239. [DOI] [PubMed] [Google Scholar]
  • 38.Ko CI, Hung CC, Chen MY, Hsueh PR, Hsiao CH, Wong JM. Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. Gastrointest Endosc. 1999;50(1):111–114. doi: 10.1016/s0016-5107(99)70359-7. [DOI] [PubMed] [Google Scholar]
  • 39.Kinder RB, Jourdan MH. Disseminated aspergillosis and bleeding colonic ulcers in renal transplant patient. J R Soc Med. 1985;78(4):338–339. doi: 10.1177/014107688507800414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sousa AB, Ferreira G, Veiga J, Carvalho A. Clinical picture: bowel infarction due to aspergillosis. Lancet. 2002;359(9302):210. doi: 10.1016/s0140-6736(02)07446-9. [DOI] [PubMed] [Google Scholar]
  • 41.Finn S, Bond J, McCarthy D, Sheahan K, Quinn C. Angioinvasive aspergillosis presenting as neutropenic colitis. Histopathology. 2006;49(4):440–441. doi: 10.1111/j.1365-2559.2006.02488.x. [DOI] [PubMed] [Google Scholar]
  • 42.Andres LA, Ford RD, Wilcox RM. Necrotizing colitis caused by systemic aspergillosis in a burn patient. J Burn Care Res. 2007;28(6):918–921. doi: 10.1097/BCR.0b013e318159a3d8. [DOI] [PubMed] [Google Scholar]
  • 43.Mohite U, Kell J, Haj MA, et al. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007;78:270–273. doi: 10.1111/j.1600-0609.2006.00812.x. [DOI] [PubMed] [Google Scholar]
  • 44.Choi SH, Chung JW, Cho SY, Kim BJ, Kwon GY. A case of isolated invasive Aspergillus colitis presenting with hematochezia in a nonneutropenic patient with colon cancer. Gut Liver. 2010;4(2):274–277. doi: 10.5009/gnl.2010.4.2.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Penna FJ. Blastomycosis of the colon resembling ulcerative colitis. Gut. 1979;20:896–899. doi: 10.1136/gut.20.10.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Chojniak R, Costa Vieira RA, Lopes A, et al. Intestinal paracoccidioidomycosis simulating colon cancer. Rev Soc Bras Med Trop. 2000;33:309–312. doi: 10.1590/s0037-86822000000300010. [DOI] [PubMed] [Google Scholar]
  • 47.Costa Vieira RA, Lopes A, Oliveira HV, et al. Anal paracoccidioidomycosis: an unusual presentation of disseminated disease. Rev Soc Med Trop. 2001;34:583–586. doi: 10.1590/s0037-86822001000600014. [DOI] [PubMed] [Google Scholar]
  • 48.Bravo EA, Zegarra AJ, Piscoya A, et al. Chronic diarrhea and pancolitis caused by paracoccidioidomycosis: case report. Case Report Med. 2010;2010:140505. doi: 10.1155/2010/140505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.León M, Alave J, Bustamante B, Cok J, Gotuzzo E, Seas C. Human T lymphotropic virus 1 and paracoccidioidomycosis: a probable association in Latin America. Clin Infect Dis. 2010;51(2):250–251. doi: 10.1086/653679. [DOI] [PubMed] [Google Scholar]
  • 50.Benard G, Costa AN, Leopércio AP, Vicentini AP, Kono A, Shikanai-Yasuda MA. Chronic paracoccidioidomycosis of the intestine as single organ involvement points to an alternative pathogenesis of the mycosis. Mycopathologia. 2013;176(5–6):353–357. doi: 10.1007/s11046-013-9699-z. [DOI] [PubMed] [Google Scholar]
  • 51.Bellomo AR, Perlman DC, Kaminsky DL, Brettholz EM, Sarlin JG. Pneumocystis colitis in a patient with the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992;87(6):759–761. [PubMed] [Google Scholar]
  • 52.Lin D, Kamili Q, Lai S, Musher DM, Hamill R. Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations. Infection. 2013;41(3):723–726. doi: 10.1007/s15010-013-0429-8. [DOI] [PubMed] [Google Scholar]
  • 53.Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology. 1967;53:845–855. [PubMed] [Google Scholar]
  • 54.Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Engl J Med. 1969;280:638–641. doi: 10.1056/NEJM196903202801204. [DOI] [PubMed] [Google Scholar]
  • 55.Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781–803. doi: 10.1086/513943. [DOI] [PubMed] [Google Scholar]
  • 56.Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am. 2002;16:875–894. doi: 10.1016/s0891-5520(02)00035-1. vi. [DOI] [PubMed] [Google Scholar]
  • 57.Smulian AG, Keely SP, Sunkin SM, Stringer JR. Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J Lab Clin Med. 1997;130(5):461–468. doi: 10.1016/s0022-2143(97)90122-0. [DOI] [PubMed] [Google Scholar]
  • 58.Daly KR, Koch J, Levin L, Walzer PD. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis. 2004;10(5):848–854. doi: 10.3201/eid1005.030497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20:507–544. doi: 10.1016/j.idc.2006.07.001. [DOI] [PubMed] [Google Scholar]
  • 60.Salkin IF, McGinnis MR, Dykstra MJ, Rinaldi MG. Scedosporium inflatum, an emerging pathogen. J Clin Microbiol. 1988;26:498–503. doi: 10.1128/jcm.26.3.498-503.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia. 1989;106:13–22. doi: 10.1007/BF00436921. [DOI] [PubMed] [Google Scholar]
  • 62.Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One. 2013;8(6):e66019. doi: 10.1371/journal.pone.0066019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20:581–607. doi: 10.1016/j.idc.2006.06.003. [DOI] [PubMed] [Google Scholar]
  • 64.Goodwin RA, Jr, Shapiro JL, Thurman GH, Thurman SS, Des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980;59:1–33. [PubMed] [Google Scholar]
  • 65.Wheat LJ, Slama TG, Eitzen HE, Kohler RB, French ML, Biesecker JL. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med. 1981;94:331–337. doi: 10.7326/0003-4819-94-3-331. [DOI] [PubMed] [Google Scholar]
  • 66.Negroni R. Paracoccidioidomycosis (South American blastomycosis, Lutz’s mycosis) Int J Dermatol. 1993;32:847–859. doi: 10.1111/j.1365-4362.1993.tb01396.x. [DOI] [PubMed] [Google Scholar]
  • 67.Blotta MH, Mamoni RL, Oliveira SJ, et al. Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg. 1999;61:390–394. doi: 10.4269/ajtmh.1999.61.390. [DOI] [PubMed] [Google Scholar]
  • 68.Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344:110–113. doi: 10.1016/s0140-6736(94)91287-4. [DOI] [PubMed] [Google Scholar]
  • 69.Wong KH, Lee SS, Lo YC, et al. Profile of opportunistic infections among HIV-1 infected people in Hong Kong. Zhonghua Yi Xue Za Zhi (Taipei) 1995;55:127–136. [PubMed] [Google Scholar]
  • 70.Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23:125–130. doi: 10.1093/clinids/23.1.125. [DOI] [PubMed] [Google Scholar]
  • 71.Wong KH, Lee SS. Comparing the first and second hundred AIDS cases in Hong Kong. Singapore Med J. 1998;39:236–240. [PubMed] [Google Scholar]
  • 72.Peña CE. Deep mycotic infections in Colombia. A clinicopathologic study of 162 cases. Am J Clin Pathol. 1967;47(4):505–520. doi: 10.1093/ajcp/47.4.505. [DOI] [PubMed] [Google Scholar]
  • 73.Eras P, Goldstein MJ, Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972;51:367–379. doi: 10.1097/00005792-197209000-00002. [DOI] [PubMed] [Google Scholar]
  • 74.Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970;49:147–173. doi: 10.1097/00005792-197003000-00002. [DOI] [PubMed] [Google Scholar]
  • 75.De Luca A, Zelante T, D’Angelo C, et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010;3(4):361–373. doi: 10.1038/mi.2010.22. [DOI] [PubMed] [Google Scholar]
  • 76.Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014;14(6):405–416. doi: 10.1038/nri3684. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Gastroenterology are provided here courtesy of Dove Press

RESOURCES